After adjusting for age, the odds of a BRCA2 mutation carrier developing MF/MC breast cancer were 3.7‐fold greater than in BRCA1 mutation carriers (CI: 1.77–7.78, p = 0.001) (Table 2). The gene discussed is BRCA2; the disease is breast carcinoma.